Trials / Recruiting
RecruitingNCT07231783
The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults
A Confirmatory, Randomised, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Effects of a Dietary Supplement Containing Urolithin A (Mitopure®) on Muscle Strength and Performance in Healthy Middle-Aged Adults
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Amazentis SA · Industry
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a randomised, double-blind, placebo-controlled, parallel study to assess the effects of Urolithin A (Mitopure®) supplementation on muscle strength and performance in healthy middle-aged adults. Participants will be randomized to consume Mitopure® (500 mg), Mitopure® (1000 mg), or placebo once daily for 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | Placebo softgels |
| DIETARY_SUPPLEMENT | Mitopure® 500mg | Softgels providing 500 mg of Mitopure® |
| DIETARY_SUPPLEMENT | Mitopure® 1000mg | Softgels providing 1000 mg of Mitopure® |
Timeline
- Start date
- 2025-12-10
- Primary completion
- 2027-10-31
- Completion
- 2027-10-31
- First posted
- 2025-11-17
- Last updated
- 2026-03-31
Locations
1 site across 1 country: Ireland
Source: ClinicalTrials.gov record NCT07231783. Inclusion in this directory is not an endorsement.